Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Analysis of prognostic factors
Open Access
- 1 March 1994
- Vol. 73 (5) , 1341-1345
- https://doi.org/10.1002/1097-0142(19940301)73:5<1341::aid-cncr2820730506>3.0.co;2-u
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Early Recognition of Hepatocellular Carcinoma Based on Altered Profiles of Alpha-FetoproteinNew England Journal of Medicine, 1993
- Transcatheter arterial embolization of hepatic neoplasmsCritical Reviews in Oncology/Hematology, 1992
- Treatment of small hepatocellular carcinomasThe Lancet, 1992
- Lipiodol computed tomography for small hepatocellular carcinomasThe Lancet, 1991
- A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in JapanCancer, 1991
- α-fetoprotein: Reevaluation in hepatologyHepatology, 1990
- Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditionsGastroenterology, 1990
- Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.Radiology, 1988
- Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases.Radiology, 1988
- Clinical features of hepatocellular carcinoma: Review of 211 patients in Hong KongCancer, 1981